COPD, also known as "smoker's cough", is a potentially fatal disease affecting 35 million people in Europe and 16 million Americans.
The U.S. Food and Drug Administration (FDA) has postponed its decision until May, pending further data.
(Written by Pauline Foret, edited by Augustin Turpin)